The National Health Service (Charges to Overseas Visitors) (Scotland) Amendment (No. 2) Regulations 2022

Madeat 11.00 a.m. on 16th June 2022

Laid before the Scottish Parliamentat 2.45 p.m. on 16th June 2022

Coming into forceat 5.00 p.m. on 16th June 2022

The Scottish Ministers make the following Regulations in exercise of the powers conferred by sections 98 and 105 of the National Health Service (Scotland) Act 19781 and all other powers enabling them to do so.

Citation and commencement1

These Regulations may be cited as the National Health Service (Charges to Overseas Visitors) (Scotland) Amendment (No. 2) Regulations 2022 and come into force at 5.00 p.m. on 16 June 2022.

Amendment of the National Health Service (Charges to Overseas Visitors) (Scotland) Regulations 19892

In schedule 1 (diseases for the treatment of which no charge is to be made) of the National Health Service (Charges to Overseas Visitors) (Scotland) Regulations 19892—

a

in the appropriate alphabetical position insert “Monkeypox”,

b

in the appropriate alphabetical position insert “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)”,

c

omit “Wuhan novel coronavirus (2019-nCoV)”.

MAREE TODDAuthorised to sign by the Scottish MinistersSt Andrew’s House,EdinburghAt 11.00 a.m. on 16th June 2022

EXPLANATORY NOTE

(This note is not part of the Regulations)

These Regulations amend the National Health Service (Charges to Overseas Visitors) (Scotland) Regulations 1989 (“the 1989 Regulations”), which provide for the making and recovery of charges for relevant services provided under the National Health Service (Scotland) Act 1978. Schedule 1 of the 1989 Regulations, as introduced by regulation 3 of the 1989 Regulations, contains a list of diseases for the treatment of which no charge is to be made.

Regulation 2 amends the 1989 Regulations to insert “Monkeypox” and “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” into schedule 1 and remove “Wuhan novel coronavirus (2019-nCoV)” which is a name no longer used from that schedule. A full impact assessment has not been produced for this instrument as no, or no significant, impact on the private, voluntary or public sector is foreseen.